Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Clinical trial NCT06990269 · RECRUITING

Trial details

NCT number: NCT06990269
Sponsor: ADARx Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy Secondary to Age-related Macular Degeneration

Start date: 2025-11-10
Primary completion: 2030-02-28
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.